Cervical Cancer Testing and How to Conduct Risk-Based Management
Lee P. Shulman, MD, FACMG, FACOG
Jeffrey T. Jensen, MD, MPH
Applying Clinical Trial Data on Newer CHCs into Real-World Patient Care
Charles Turck, PharmD, BCPS, BCCCP
Lincoln Nadauld, MD, PhD
Advancements in Cancer Screening Technology: Multicancer Early Detection
David L. Eisenberg, MD, MPH, FACOG
David J. Portman, MD
Contraception: Focus on Vaginal pH Modulation
Uterine Fibroids: Focus on Medical Management
Richard T. Penson, MD, MRCP
Nicoletta Colombo, MD
Keeping Pace in Women’s Cancer: Targeting Advanced Endometrial Cancer
A New Nonhormonal Contraceptive Choice: The Vaginal pH Modulator
Suhkbir Sony Singh, MD
Optimizing Medical Management of Uterine Fibroids
Anita L. Nelson, MD
Brooke M. Faught, DNP, WHNP-BC,NCMP, IF
Paul Nyirjesy, MD
Gregory Pokrywka MD, FACP, FNLA, FASPC, NCMP
Karol Watson, MD, PhD
Women's Health 2021: Beyond the Annual Visit - Midwest
Women's Health 2021: Beyond the Annua...
October 22, 2021
08:00 AM - 04:00 PM CDT
Andrew M. Kaunitz, MD, FACOG
New CHCs: Native Estrogen with Specific Actions in Tissues (NEST)
The Evolution of Estrogen in Contraception—From E1 to E4
Expanding Choices in Combined Hormonal Contraceptives—The Contraceptive Patch
Stephen M. Cohen, MD, FACOG
Individualizing Treatment Strategies for Endometriosis
Clinical & Practical Perspectives in Menopause Management
The Creeping Pearl Index: Distinguishing Between Clinical Trial Efficacy and ...
Eliot Brinton, MD, FAHA, FNLA
Erin D. Michos, MD, MHS, FACC, FAHA, FASE
The New Role of Omega-3 Fatty Acids in Reducing ASCVD Risk in Women: Expert Dialogue
The New Role of Omega-3 Fatty Acids in Reducing ASCVD Risk in Women: Expert D...
Stay current with the best on medical education
We’re glad to see you’re enjoying Omnia Education…but how about a more personalized experience?
Press cancel to remain on Omnia Education. Press the link below or the continue button to keep going.